Our vision is to defeat cancer and advance health equity for ALL communities through patient-centric social innovation and intentional, mission-aligned impact investing.
BrightEdge exists to accelerate the American Cancer Society's goal to reduce cancer mortality, end pain and suffering, and advance health equity Learn how BrightEdge will help improve 1.5 million lives by investing in cancer-focused therapies and technologies in its most recent annual report and infographic.
About
Project HEALTH: Applications Are Now Open
Project HEALTH aims to accelerate and amplify the impact of companies developing solutions to address healthcare disparities, reduce access barriers, and promote health equity. This accelerator program will leverage the American Cancer Society's expertise in the social drivers of health, empowering entrepreneurs to develop innovative solutions so everyone can have the opportunity to prevent, detect, treat, and survive cancer. Apply now to become a part of the inaugural Project HEALTH cohort to deepen your company's ability to make a significant impact in cancer care.
Investing for science, social impact, and sustainability
BrightEdge invests in entrepreneurial early-stage companies developing cutting-edge cancer-focused therapeutics, diagnostics, devices, and technologies to bring innovative solutions to market.
Portfolio
Fighting for a World Without Cancer
BrightEdge is led by a world-class team of investors, operators, and entrepreneurs to accelerate the commercialization of the breadth of solutions needed to target cancer from all perspectives.
Team
